Questions about this study?
The HopeStage team will email you.
WithdrawnNCT02418702
A Study to Decrease Suicidal Thinking Using Ketamine
Medication studyAges 18–65United StatesDepression
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- San DiegoSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateEstimated: August 2016
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- United States Naval Medical Center, San Diego
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Medication / drug, OTHER
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02418702
- Official title
Show the full official title
A Randomized Controlled Trial to Decrease Suicidal Thinking Using Ketamine
Recruitment & locations
WithdrawnSan Diego
A listed location does not confirm current availability.
Questions about this study
Who is behind this study?
The study sponsor is United States Naval Medical Center, San Diego, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including 0.2 mg/kg ketamine.
Who can participate?
Listed age limits: 18 years to 65 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
Want to find a study that may fit you better?
Explore HopeStage studies by mental health topic and refine the results to suit your situation.
Find a study that may fit me